Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Typhax safety and immunogenicity in healthy adults
NCT03926455Phase 1Completed
- Sponsor
- Matrivax
- Start
- Mar 2016
- Primary completion
- Feb 2017
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 1, randomised, double-blind trial of Typhax in typhoid fever (5 arms), sponsored by Matrivax. Primary endpoints: Number of participants reporting solicited injection site and systemic events, Number of participants reporting adverse events and 2 more. Started Mar 2016; status: completed.
02
Drugs
Typhax
03
Conditions
typhoid fever
Beyond the preview
Go deeper on NCT03926455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03926455.